Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

FDA halts BioMarin’s PKU gene therapy trial

September 7, 2021 Manufacturing and Production, Medical Communications, Research and Development

BioMarin Pharma has announced that the FDA has slapped a clinical hold on its Phase 1/2 trial of its candidate …
News

Vaginal ring could help prevent HIV infection in women

September 7, 2021 Manufacturing and Production, Research and Development

Researchers from the Kenya Medical Research Institute (KEMRI) are exploring the use of an intra vaginal ring containing anti-HIV medication …
News

Sinovac booster jab reverses antibody drop from Delta variant, study finds

September 6, 2021 Medical Communications, Research and Development, Sales and Marketing

Researchers have found that a booster shot of Sinovac’s COVID-19 vaccine reverses a decline in antibody activities against the Delta …
News
astrazeneca_sign_sky

AstraZeneca’s Ultomiris approved for use on children in EU

September 3, 2021 Medical Communications, Research and Development

AstraZeneca has gained EU approval for its rare blood disorder drug, Ultomiris, for use in children. The drug was developed …
News
andrei_r_-_shutterstock_1935537274_720

NICE and Cochrane to collaborate on living recommendations

September 1, 2021 Medical Communications, Research and Development

NICE has announced a collaboration with Cochrane, in which Cochrane will help deliver ‘living’ recommendations across the NICE guideline portfolio. …
News

Viper venom found to inhibit COVID virus from multiplying

September 1, 2021 Medical Communications, Research and Development

Brazilian researchers have found that a molecule in the venom of a jararacussu pit viper can prevent coronavirus reproduction. The …
News
annie-spratt-yiiz4olewg4-unsplash_1

AI test screens for COVID-19 26% faster than lateral flow tests

September 1, 2021 Research and Development

A University of Oxford-led study has shown that COVID-19 screening results were available 45 minutes after patients arrived in the …
News
moderna_norwood_plant

Fourth contaminated Moderna vial found in Japan

September 1, 2021 Medical Communications, Research and Development

A fourth contamination case in less than a week in Japan has been reported involving Moderna’s COVID-19 vaccine, which threatens …
News

NICE approves life-saving cholesterol drug for NHS

September 1, 2021 Research and Development

NICE has approved the ground-breaking cholesterol-lowering drug inclisiran, made by Novartis, for use on the NHS. This is an option …
News

Malaria sickness could be cut by 70%, study finds

August 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have found a new approach to protecting young African …
News

Trial planned to investigate ketamine in treatment-resistant depression

August 25, 2021 Research and Development

HMNC Brain Health and Develco Pharma have partnered to develop an investigational oral prolonged-release formulation of ketamine, targeting treatment-resistant depression …
News
mark

Stelis Biopharma appoints Mark Womack as new CEO

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Stelis Biopharma Limited has announced the appointment of Mark W Womack as the new Chief Executive Officer.Womack is also the …
Appointment

PureTech appoints Julie Krop as Chief Medical Officer

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.Krop will oversee all clinical development, Regulatory, CMC, and …
Appointment

Tracey Lodie appointed Chief Scientific Officer of Quell Therapeutics

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Quell Therapeutics has announced the appointment of Tracey Lodie as Chief Scientific Officer.Dr Lodie brings to Quell more than 20 …
Appointment
anita_cooper_002

RareCan appoints Dr Anita Cooper as Non-Executive Director

August 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cancer research company RareCan has appointed Dr Anita Cooper as Non-Executive Director.Cooper has over 30 years’ experience in global business …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026